Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Tests for Parkinson's within Reach

    Tests for Parkinson's within Reach

    Parkinson's scientists say tests to predict the course of the disease are within reach thanks to investment in large-scale studies and standardized methods.
    Learn more Save for later
  • What We Fund: Brain's Resilience, Asthma Drug for Parkinson's and Signs of Disease in the Eye

    What We Fund: Brain's Resilience, Asthma Drug for Parkinson's and Signs of Disease in the Eye

    Foundation-funded research lays groundwork to deepen understanding of Parkinson's and speed breakthroughs.
    Learn more Save for later
  • 'Scientific American' Talks LRRK2 and Parkinson's Research with MJFF CEO Todd Sherer

    'Scientific American' Talks LRRK2 and Parkinson's Research with MJFF CEO Todd Sherer

    An MJFF-funded study suggests that a drug targeting the LRRK2 genetic mutation may positively impact the broader PD population.
    Learn more Save for later
  • Latest Stem Cell Trial Attempts New Approach to Treating Parkinson's

    Latest Stem Cell Trial Attempts New Approach to Treating Parkinson's

    A team at Kyoto University will lead the first clinical trial using iPS cells on Parkinson's disease.
    Learn more Save for later
  • New Podcast on Parkinson's, Gaucher and GBA

    New Podcast on Parkinson's, Gaucher and GBA

    A podcast from the National Gaucher Foundation covers the genetic connection between Parkinson's and Gaucher diseases and new treatments in the works.
    Learn more Save for later
  • Positive Results from Parkinson's LRRK2 Drug Trial

    Positive Results from Parkinson's LRRK2 Drug Trial

    Denali will move its drug into trials with patients with or without a LRRK2 mutation after new research points to potential widespread use of these therapies.
    Learn more Save for later
  • Regulators Endorse First Imaging Test for Parkinson's Disease Clinical Trials

    Regulators Endorse First Imaging Test for Parkinson's Disease Clinical Trials

    The European Medicines Agency has, for the first time, supported a brain scan to help choose trial participants. It could speed drug trials and improve their chances of success.
    Learn more Save for later
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.